D
MediWound Ltd. MDWD
$17.50 $0.372.16% NASDAQ
Recommendation
Dividend Power Score
Prev Close
$17.13
Volume
8,653
Avg Vol (90D)
88,925
Market Cap
$219.63M
Dividend & Yield
--
52-Week Range
$14.14 - $22.51
P/E (TTM)
--
EPS (TTM)
-$2.57
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
MediWound (MDWD, $17.09) Stochastic Oscillator left the oversold zone on February 12, 2026
2/13/2026 - Tickeron - Stocks
MediWound Ltd. (NASDAQ:MDWD) Given Average Recommendation of "Moderate Buy" by Analysts
2/12/2026 - Ticker Report
MediWound (MDWD, $17.79) entered Uptrend as Momentum indicator ascends above 0 level on Feb 06, 2026
2/7/2026 - Tickeron - Stocks
MediWound (MDWD, $17.22) entered Downtrend as Momentum indicator drops below 0 level on Feb 05, 2026
2/6/2026 - Tickeron - Stocks
MediWound (MDWD, $18.1) price exceeded its 50-day Moving Average on February 02, 2026
2/3/2026 - Tickeron - Stocks
MediWound (MDWD, $18.13) price moved above its 50-day Moving Average on January 30, 2026
1/31/2026 - Tickeron - Stocks
MediWound (MDWD, $17.65) price exceeded its 50-day Moving Average on January 29, 2026
1/30/2026 - Tickeron - Stocks
MediWound's EscharEx: A Late-Stage Asset Built for a Re-Normalized Wound Care Market (NASDAQ: MDWD)
1/29/2026 - GuruFocus
MediWound (MDWD, $18.42) price moved above its 50-day Moving Average on January 28, 2026
1/29/2026 - Tickeron - Stocks
MediWound (MDWD, $18.03) entered Uptrend as Momentum indicator ascends above 0 level on Jan 27, 2026
1/28/2026 - Tickeron - Stocks
MediWound (MDWD, $17.7) Stochastic Oscillator left the oversold zone on January 23, 2026
1/24/2026 - Tickeron - Technical Analysis
Correction: FDA aware of Integra recommending removal of MediHoney Wound
1/23/2026 - TipRanks Financial Blog
FDA aware of Integra recommending removal of MediWound, CVS Wound Gel products
1/22/2026 - TipRanks Financial Blog
FDA aware of Integra recommending removal of MediWound, CVS Wound Gel products
1/22/2026 - The Fly
FDA aware of Integra recommending removal of MediWound, CVS Wound Gel products
1/22/2026 - The Fly
Meitav Investment House Ltd. Has $5.24 Million Stock Holdings in MediWound Ltd. $MDWD
1/18/2026 - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) Given Consensus Recommendation of "Moderate Buy" by Analysts
1/18/2026 - MarketBeat
MediWound (NASDAQ:MDWD) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?
1/17/2026 - MarketBeat
MediWound (MDWD, $16.5) Stochastic Oscillator left the oversold zone on January 13, 2026
1/14/2026 - Tickeron - Stocks
MediWound (MDWD, $16.5) RSI Indicator left the oversold zone on January 13, 2026
1/14/2026 - Tickeron - Stocks
We Think MediWound (NASDAQ:MDWD) Can Afford To Drive Business Growth
1/14/2026 - Simply Wall St
MediWound (MDWD, $17.23) price may climb as it broke lower Bollinger Band on Jan 12, 2026
1/13/2026 - Tickeron - Stocks
MediWound (MDWD, $17.23) price exceeded its 50-day Moving Average on January 12, 2026
1/13/2026 - Tickeron - Stocks
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB), Mediwound (MDWD) and Argenx Se (ARGX)
1/13/2026 - TipRanks Financial Blog
MediWound sees FY25 revenue $17M, consensus $22.98M
1/12/2026 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$67.00M
Total Debt (Q)
$8.07M
Total Liabilities (Q)
$46.88M
Book Value Per Share (Q)
$1.85
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
(est)
Price History
Loading...
Beta
0.76
7-Day Total Return
-0.68%
30-Day Total Return
-5.20%
60-Day Total Return
-4.79%
90-Day Total Return
-1.19%
Year to Date Total Return
-4.99%
1-Year Total Return
-6.02%
2-Year Total Return
37.47%
3-Year Total Return
42.16%
5-Year Total Return
-57.84%
52-week Low
Apr 07, 2025 - $14.14
52-week High
Jun 02, 2025 - $22.51
Valuation
Market Cap
$219.63M - Micro Cap
Enterprise Value
$168.81M
Price/Sales (TTM)
11.67
Price/Book (Q)
9.26
Dividends and Shares
Shares Outstanding
10.84M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.mediwound.com
Phone Number
972 7 797 14100
Address
42 Hayarkon Street
Yavne, 8122745
Country
Israel
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States... more
NASDAQ 02/13/2026 11:15AM Eastern Quotes delayed